Aggressive policies that target the use and promotion of off-label use are needed to prevent the use of drugs for non-approved indications with little benefit or with harmful outcomes. It should be ...
Everyday Health on MSN
Beyond insulin: Using Ozempic and other off-label drugs for type 1 diabetes
Explore the potential benefits and risks of using type 2 diabetes drugs like Ozempic and metformin off-label to manage weight ...
Kids ages 5 to 11 can now be vaccinated against COVID-19 following the Food and Drug Administration’s emergency use authorization of the Pfizer Bio-NTech vaccine for this age group and the Centers for ...
In a recent national survey, a substantial minority of physicians erroneously believed that certain off-label uses of prescription drugs were approved by the Food and Drug Administration. This ...
Doctors often prescribe antidepressants to tackle conditions like migraine headaches for which they aren’t technically approved. Now, researchers say such “off-label” usage mostly occurs without clear ...
The majority of patients prescribed antipsychotic medications in state Medicaid programs are taking these agents for off-label indications. Continuously enrolled patients with at least 1 prescription ...
The Food and Drug Administration (FDA) authorizes the marketing of drugs only for uses that the manufacturer has demonstrated to be safe and effective. However, the FDA does not regulate medical ...
Dabigatran has been readily integrated into clinical practice in the United States, primarily for treatment of atrial fibrillation (A-fib) but increasingly for off-label indications as well, according ...
Both the U.S. Court of Appeals for the Second Circuit and district courts have ruled against the Food and Drug Administration (FDA) in two widely publicized cases involving the agency’s enforcement of ...
Testing for Discordance at Metastatic Relapse: Does It Matter? Off-label drug use refers to the prescription of licensed drugs for clinical indications or in a manner different from that approved by ...
The Food and Drug Administration has relaxed label requirements for taking the abortion-inducing mediation Mifeprex (mifepristone), a move that may make it easier to prescribe the drug in states that ...
The Food and Drug Administration (FDA) has approved new labeling for Naftin (naftifine HCl cream 2%; Merz Pharmaceuticals) adding additional information regarding use in the pediatric population. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results